Chemotherapy and targeted therapy for patients with human epidermal growth factor receptor 2–negative metastatic breast cancer that is either endocrine-pretreated …

B Moy, RB Rumble, SE Come, NE Davidson… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This guideline updates recommendations of the ASCO guideline on
chemotherapy and targeted therapy for patients with human epidermal growth factor …
被引用次数：66 相关文章

Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of …, 2021 - mdanderson.elsevierpure.com
PURPOSE This guideline updates recommendations of the ASCO guideline on
chemotherapy and targeted therapy for patients with human epidermal growth factor …

Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of …, 2021 - utsouthwestern.elsevierpure.com
PURPOSE This guideline updates recommendations of the ASCO guideline on
chemotherapy and targeted therapy for patients with human epidermal growth factor …

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose This guideline updates recommendations of the ASCO guideline on chemotherapy
and targeted therapy for patients with human epidermal growth factor receptor 2-negative …

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of Clinical …, 2021 - europepmc.org
Purpose This guideline updates recommendations of the ASCO guideline on chemotherapy
and targeted therapy for patients with human epidermal growth factor receptor 2-negative …

Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of Clinical …, 2021 - experts.umn.edu
PURPOSE This guideline updates recommendations of the ASCO guideline on
chemotherapy and targeted therapy for patients with human epidermal growth factor …

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE This guideline updates recommendations of the ASCO guideline on
chemotherapy and targeted therapy for patients with human epidermal growth factor …

Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, RB Rumble, SE Come… - Journal of Clinical …, 2021 - mayoclinic.elsevierpure.com
PURPOSE This guideline updates recommendations of the ASCO guideline on
chemotherapy and targeted therapy for patients with human epidermal growth factor …

Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine …

B Moy, A Di Leo, LA Carey, M Del Re… - Journal of Clinical …, 2021 - Elsevier
Angelo Di Leo | ScienceDirect Skip to main content Elsevier logo Journals & Books Search
RegisterSign in Angelo Di Leo Author information Author information Current affiliation: Hospital …